Finance News – Regeneron Pharmaceuticals

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Stocks Shares Tariffs Stock Investors Ceo Stock Market Crypto Assets Ethereum Cryptocurrency Price Markets Xrp Eth Etf Bse Earnings Ipo Stablecoin Investment Blockchain Revenue Solana Index Trade Sec Inflation Interest Rates Wall Street Token Sensex Coinbase Treasury Federal Reserve Nasdaq Traders Profit Nse China Nifty Bse Sensex Sp 500 Investor Gold Tesla Company Economy Validator Headcount Btc Etfs Stock Acquisition Rights Trump Memecoins Eureka Prospect Midcap Companies Child Safety Crisis Flight Segment Cap

Filter by:

Regeneron Pharmaceuticals ×

CNBC Business • May 27, 2025

23andMe to delist from Nasdaq, deregister with SEC

The planned acquisition of most 23andMe assets by Regeneron Pharmaceuticals for $256 million will result in the company's withdrawal from public stock trading and regulatory report...

Read Full Article →

The Guardian – Business • May 19, 2025

Bankrupt DNA testing firm 23andMe to be purchased for $256m

Regeneron Pharmaceuticals’ acquisition of a consumer genetic testing company for $256 million during bankruptcy highlights a significant investment in genetic data assets, promptin...

Read Full Article →

CBC Business • May 19, 2025

Bankrupt DNA testing company 23andMe to be bought by Regeneron

Regeneron’s acquisition of the financially troubled DNA testing firm could impact the handling of extensive genetic data, while addressing concerns about privacy and potential misu...

Read Full Article →